Skip to main content
C

CiderBiotech

CiderBiotech offers the FleX Switch™ platform, a bio‑engineering toolkit that creates enzyme‑based protein switches customized for a wide range of ligands—including ions, small molecules, peptides, proteins, DNA and RNA. Its modular architecture lets developers convert any sensing input into a selectable reporting output, supporting assay formats from high‑throughput labs to point‑of‑care and wearable devices, thereby speeding development and expanding diagnostic and industrial biosensor capabilities.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Developing reliable, customizable biosensors for detecting a wide range of biological targets often requires extensive protein engineering and integration with hardware, leading to long development cycles and limited assay flexibility.

Solution

CiderBiotech’s FleX Switch™ platform provides a bio‑engineering toolkit that creates enzyme‑based protein switches tailored to specific ligands, including ions, small molecules, peptides, proteins, DNA and RNA. The modular architecture converts virtually any sensing input into a selectable reporting output, enabling developers to design assays for laboratory, point‑of‑care, or wearable formats. By engineering bespoke biosensors rather than relying on natural proteins, the platform accelerates assay development and expands the range of detectable targets for diagnostic, therapeutic and industrial applications.

Target Audience

Primary customers are biotech assay developers, diagnostic manufacturers, and industrial R&D teams seeking customizable biosensor solutions for medical and non‑medical applications.

Features

  • Enzyme‑based protein switches engineered for high specificity toward diverse targets (ions, metabolites, biomarkers, nucleic acids)
  • Modular design allowing interchangeable sensing domains and output reporters to suit any assay format
  • Compatibility with high‑throughput laboratory workflows, point‑of‑care devices, and wearable sensors
  • Scalable production pipeline for rapid prototyping and commercial‑grade manufacturing of custom biosensors
  • Integrated assay development support enabling rapid translation from concept to validated test
This profile is AI-generated and may contain inaccuracies.